fda bpc-157 compounding safety concerns warning unapproved peptide In 2023, the FDA deemed 19 peptide drugs too unsafe The FDA just announced that
Description
The regional serotonin synthesis (using alpha-[14C]methyl-L-tryptophan (-MTrp) autoradiographic measurements) in the brain following peripheral (intraperitoneal) BPC 157 administration is subjected to particular, likely indicative changes, timely and brain areas specific [67]
C., & Lin, P

In addition, age plays an important factor

As clinical signs of cobalamin deficiency include chronic wasting or failure to thrive, malaise, and gastrointestinal signs such as diarrhea, serum cobalamin concentration should be measured in any dog with poor response to enzyme replacement therapy for EPI

Week one is protected weight-bearing in a surgical boot